Trial Profile
Cohort study of bevacizumab in combination with XELOX for metastatic colorectal cancer
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 13 Nov 2015
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Capecitabine (Primary) ; Oxaliplatin (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 09 Apr 2013 New trial record